| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $350.6M | +12.0% |
| Cost of Revenue | $223.6M | +11.9% |
| Gross Profit | $127.0M | +12.2% |
| R&D Expense | $18.3M | +24.5% |
| SG&A Expense | $82.1M | +2.9% |
| Operating Income | -$2.1M | +62.3% |
| Pre-tax Income | $11.1M | +128.5% |
| Income Tax | $7.0M | +6.2% |
| Net Income | $4.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334.7M | +30.1% |
| Accounts Receivable | $69.4M | +39.2% |
| Current Assets | $423.3M | +30.7% |
| Total Assets | $592.2M | +36.1% |
| Current Liabilities | $55.5M | +31.5% |
| Total Liabilities | $74.4M | +42.3% |
| Stockholders' Equity | $517.8M | +35.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.2M | -26.5% |
| Capital Expenditures | $11.8M | +49.5% |
| Investing Cash Flow | -$51.3M | -97.7% |
| Financing Cash Flow | $101.2M | +719.8% |
| Free Cash Flow | $18.4M | -44.5% |
| +329.0% |
| EPS (Basic) | $0.05 | +350.0% |
| EPS (Diluted) | $0.05 | +350.0% |